Hagerty David T
Insider CIK 1513859 · RDEA Senior VP & CMO · CNAT EVP, Clinical Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-02-07 | 2019-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-02-04 | 2018-02-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-01-26 | 2017-02-01 | 100,625 | — | $0 | 100,625 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 109,375 | — | $0 | 109,375 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 21,875 | — | $0 | 21,875 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-10-01 | 2014-10-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 33,600 | $13.06 | $438.8K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 15,384 | $6.00 | $92.3K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 134,616 | $6.00 | $807.7K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer | 2012-06-19 | 2012-06-20 | 140 | $32.00 | $4.5K | 0 | SEC↗ |